La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Mirum Pharmaceuticals Bilan de santé
Santé financière contrôle des critères 4/6
Mirum Pharmaceuticals has a total shareholder equity of $229.0M and total debt of $307.2M, which brings its debt-to-equity ratio to 134.2%. Its total assets and total liabilities are $660.8M and $431.8M respectively.
Informations clés
134.2%
Ratio d'endettement
US$307.24m
Dette
Ratio de couverture des intérêts | n/a |
Argent liquide | US$278.37m |
Fonds propres | US$228.99m |
Total du passif | US$431.77m |
Total des actifs | US$660.75m |
Mises à jour récentes de la santé financière
Recent updates
Bullish On Mirum Pharmaceuticals: Enhanced Portfolio With Strategic Acquisition
Jul 17Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Fly 46% But Investors Aren't Buying For Growth
Jul 13Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Business And Shares Still Trailing The Industry
May 28Mirum Pharmaceuticals: After Phase 2 Miss, An iBAT Inhibitor On Deck To Drive Value
Apr 22Mirum Pharmaceuticals: Advancing On Several Key Fronts
Mar 05There's Reason For Concern Over Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Price
Dec 26What Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) P/S Is Not Telling You
Jun 10Industry Analysts Just Made A Captivating Upgrade To Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Revenue Forecasts
Apr 18Mirum's liver disease drug Livmarli gets EMA committee nod for approval in EU
Oct 14Mirum: Great Sales Start For Livmarli Paves The Way For Long-Term Growth
Aug 17Mirum Pharmaceuticals announces $80M stock offering
Aug 09Mirum Pharmaceuticals: Post-Approval Execution Looks Excellent
May 27Is Mirum Pharmaceuticals (NASDAQ:MIRM) In A Good Position To Invest In Growth?
Apr 22Analyse de la situation financière
Passif à court terme: Les actifs à court terme de MIRM ( $367.8M ) dépassent ses passifs à court terme ( $112.3M ).
Passif à long terme: Les actifs à court terme de MIRM ( $367.8M ) dépassent ses passifs à long terme ( $319.5M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: MIRM's net debt to equity ratio (12.6%) is considered satisfactory.
Réduire la dette: MIRM's debt to equity ratio has increased from 0.9% to 134.2% over the past 5 years.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: MIRM has sufficient cash runway for more than 3 years based on its current free cash flow.
Prévisions de trésorerie: Insufficient data to determine if MIRM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.